- The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia. Del Poeta, G., Del Principe, M.I., Consalvo, M.A., Maurillo, L., Buccisano, F., Venditti, A., Mazzone, C., Bruno, A., Gianní, L., Capelli, G., Lo Coco, F., Cantonetti, M., Gattei, V., Amadori, S. Cancer (2005)